虚拟护理为患有高级分化的胃肠道胰腺神经内分泌瘤 (GEP-NET) 的患者提供
William J Phillips1, Michelle Pradier2, Rachel Goodwin3
1Division of Medical Oncology, The University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Current oncology (Toronto, Ont.)
|February 23, 2024
概括
在大流行期间,虚拟护理对于胃肠道胰腺神经内分泌瘤 (GEP-NET) 患者变得至关重要. 持续使用虚拟随访可以改善获得专门的神经内分泌癌症护理的机会.
科学领域:
- 在瘤学瘤学.
- 数字健康数字健康
- 提供癌症护理 提供癌症护理
背景情况:
- 在全球范围内,COVID-19大流行加速了虚拟癌症护理的采用.
- 胃肠道胰腺神经内分泌瘤 (GEP-NETs) 需要专门的,持续的治疗.
- 在疫情期间,GEP-NET患者的转向虚拟护理是前所未有的.
研究的目的:
- 评估GEP-NET患者虚拟护理的利用和模式.
- 评估大流行病对GEP-NET在一个主要的学术中心的护理服务的影响.
- 在GEP-NET管理中识别与虚拟护理使用相关的因素.
主要方法:
- 追溯性,观察性研究设计.
- 包括在医疗瘤咨询中看到的成年GEP-NET患者.
- 从2019年6月到2022年12月,收集有关人口统计,临床病理特征,治疗和访问类型的数据.
主要成果:
- 分析了103名具有差异化良好GEP-NET的患者.
- 17.5%的初始咨询和76.1%的随访是虚拟的.
- 虚拟后续使用在流行病后 (67.0%在2022年,41.4%在2023年) 持续存在,受后续年,性别,就业和并发症指数的影响.
结论:
- 在大流行和大流行前期间,虚拟护理是GEP-NET评估的主要方式.
- 这项研究表明,虚拟护理在管理GEP-NET中发挥着持续的作用.
- 持续的虚拟护理可以提高获得子专业神经内分泌瘤专业知识的机会.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
90
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
90
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
01:15Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
136
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
136
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
303
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
303